Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background

The evolution of drug-resistance in pathogens is a major global health threat. Elucidating the molecular basis of pathogen drug-resistance has been the focus of many studies but rarely is it known whether a drug-resistance mechanism identified is universal for the studied pathogen; it has seldom been clarified whether drug-resistance mechanisms vary with the pathogen's genotype. Nevertheless this is of critical importance in gaining an understanding of the complexity of this global threat and in underpinning epidemiological surveillance of pathogen drug resistance in the field. This study aimed to assess the molecular and phenotypic heterogeneity that emerges in natural parasite populations under drug treatment pressure. We studied lines of the protozoan parasite Leishmania (L.) donovani with differential susceptibility to antimonial drugs; the lines being derived from clinical isolates belonging to two distinct genetic populations that circulate in the leishmaniasis endemic region of Nepal. Parasite pathways known to be affected by antimonial drugs were characterised on five experimental levels in the lines of the two populations. Characterisation of DNA sequence, gene expression, protein expression and thiol levels revealed a number of molecular features that mark antimonial-resistant parasites in only one of the two populations studied. A final series of in vitro stress phenotyping experiments confirmed this heterogeneity amongst drug-resistant parasites from the two populations. These data provide evidence that the molecular changes associated with antimonial-resistance in natural Leishmania populations depend on the genetic background of the Leishmania population, which has resulted in a divergent set of resistance markers in the Leishmania populations. This heterogeneity of parasite adaptations provides severe challenges for the control of drug resistance in the field and the design of molecular surveillance tools for widespread applicability

Deflazacort for the treatment of Duchenne Dystrophy: A systematic review

BACKGROUND: To complete a systematic review and meta-analysis based on the clinical question: Is Deflazacort (DFZ), a prednisolone derivative, an effective therapy for improving strength, with acceptable side effects, in children with Duchenne Dystrophy (DD)? METHODS: MEDLINE, EMBASE, Current Contents, Dissertation Abstracts, Health Star, PsychINFO and Cochrane, were searched using the following inclusion criteria: 1) A randomized controlled trial comparing DFZ with placebo or another therapy; 2) Male participants age 2–18 years with DD; 3) Outcomes of (a) any form of strength or functional testing, or (b) any form of side effect. RESULTS: Fifteen studies of potential relevance were identified, with five meeting the inclusion criteria. These five studies included 291 children and were published in English language journals between 1994 and 2000. Two studies compared DFZ versus placebo, two studies compared DFZ with prednisone and one study had both placebo and prednisone comparisions. Two large trials were identified that have not been published in article format. Due to the heterogeneity in outcome measures and the inconsistent reporting of summary statistics a meta-analytic approach could not be taken. CONCLUSIONS: Examining individual studies it appears that DFZ improves strength and functional outcomes compared to placebo, but it remains unclear if it has a benefit over prednisone on similar outcomes. Two trials found that DFZ causes less weight gain than prednisone

Stratification and therapeutic potential of PML in metastatic breast cancer.

Patient stratification has been instrumental for the success of targeted therapies in breast cancer. However, the molecular basis of metastatic breast cancer and its therapeutic vulnerabilities remain poorly understood. Here we show that PML is a novel target in aggressive breast cancer. The acquisition of aggressiveness and metastatic features in breast tumours is accompanied by the elevated PML expression and enhanced sensitivity to its inhibition. Interestingly, we find that STAT3 is responsible, at least in part, for the transcriptional upregulation of PML in breast cancer. Moreover, PML targeting hampers breast cancer initiation and metastatic seeding. Mechanistically, this biological activity relies on the regulation of the stem cell gene SOX9 through interaction of PML with its promoter region. Altogether, we identify a novel pathway sustaining breast cancer aggressiveness that can be therapeutically exploited in combination with PML-based stratification.The work of A.C. is supported by the Ramón y Cajal award, the Basque Department of Industry, Tourism and Trade (Etortek), Health (2012111086) and Education (PI2012-03), Marie Curie (277043), Movember Foundation (GAP1), ISCIII (PI10/01484, PI13/00031), FERO (VIII Fellowship) and ERC (336343). N.M.-M. and P.A. are supported by the Spanish Association Against Cancer (AECC), AECC JP Vizcaya and Guipuzcoa, respectively. J.U. and F.S. are Juan de la Cierva Researchers (MINECO). L.A., A.A.-A. and L.V.-J. are supported by the Basque Government of education. M.L.-M.C. acknowledges SAF2014-54658-R and Asociación Española contra el Cancer. R.B. acknowledges Spanish MINECO (BFU2014-52282-P, Consolider BFU2014-57703-REDC), the Departments of Education and Industry of the Basque Government (PI2012/42) and the Bizkaia County. M.S., V.S. and J.B. acknowledge Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (Tumour Biomarker Research Program). M.S. and J.B. are supported by NIH grant P30 CA008748. M.dM.V. is supported by the Institute of Health Carlos III (PI11/02251, PI14/01328) and Basque Government, Health Department (2014111145). A.M. is supported by ISCIII (CP10/00539, PI13/02277) and Marie Curie CIG 2012/712404. V.S. is supported by the SCIII (PI13/01714, CP14/00228), the FERO Foundation and the Catalan Agency AGAUR (2014 SGR 1331). R.R.G. research support is provided by the Spanish Ministry of Science and Innovation grant SAF2013-46196, BBVA Foundation, the Generalitat de Catalunya (2014 SGR 535), Institució Catalana de Recerca i Estudis Avançats, the Spanish Ministerio de Economia y Competitividad (MINECO) and FEDER funds (SAF2013-46196).This is the final version of the article. It first appeared from Nature Publishing Group via http://dx.doi.org/10.1038/ncomms1259

Differential Effects of Aerobic Exercise, Resistance Training and Combined Exercise Modalities on Cholesterol and the Lipid Profile:Review, Synthesis and Recommendations

There is a direct relationship between chronically elevated cholesterol levels (dyslipidaemia) and coronary heart disease. A reduction in total cholesterol is considered the gold standard in preventative cardiovascular medicine. Exercise has been shown to have positive impacts on the pathogenesis, symptomatology and physical fitness of individuals with dyslipidaemia, and to reduce cholesterol levels. The optimal mode, frequency, intensity and duration of exercise for improvement of cholesterol levels are, however, yet to be identified. This review assesses the evidence from 13 published investigations and two review articles that have addressed the effects of aerobic exercise, resistance training and combined aerobic and resistance training on cholesterol levels and the lipid profile. The data included in this review confirm the beneficial effects of regular activity on cholesterol levels and describe the impacts of differing volumes and intensities of exercise upon different types of cholesterol. Evidence-based exercise recommendations are presented, aimed at facilitating the prescription and delivery of interventions in order to optimize cholesterol levels

Selection for environmental variance of litter size in rabbits

[EN] Background: In recent years, there has been an increasing interest in the genetic determination of environmental variance. In the case of litter size, environmental variance can be related to the capacity of animals to adapt to new environmental conditions, which can improve animal welfare. Results: We developed a ten-generation divergent selection experiment on environmental variance. We selected one line of rabbits for litter size homogeneity and one line for litter size heterogeneity by measuring intra-doe phenotypic variance. We proved that environmental variance of litter size is genetically determined and can be modified by selection. Response to selection was 4.5% of the original environmental variance per generation. Litter size was consistently higher in the Low line than in the High line during the entire experiment. Conclusions: We conclude that environmental variance of litter size is genetically determined based on the results of our divergent selection experiment. This has implications for animal welfare, since animals that cope better with their environment have better welfare than more sensitive animals. We also conclude that selection for reduced environmental variance of litter size does not depress litter size.This research was funded by the Ministerio de Economía y Competitividad (Spain), Projects AGL2014-55921, C2-1-P and C2-2-P. Marina Martínez-Alvaro has a Grant from the same funding source, BES-2012-052655.Blasco Mateu, A.; Martínez Álvaro, M.; García Pardo, MDLL.; Ibáñez Escriche, N.; Argente, MJ. (2017). Selection for environmental variance of litter size in rabbits. Genetics Selection Evolution. 49(48):1-8. https://doi.org/10.1186/s12711-017-0323-4S184948Morgante F, Sørensen P, Sorensen DA, Maltecca C, Mackay TFC. Genetic architecture of micro-environmental plasticity in Drosophila melanogaster. Sci Rep. 2015;5:9785.Sørensen P, de los Campos G, Morgante F, Mackay TFC, Sorensen D. Genetic control of environmental variation of two quantitative traits of Drosophila melanogaster revealed by whole-genome sequencing. Genetics. 2015;201:487–97.Zhang XS, Hill WG. Evolution of the environmental component of the phenotypic variance: stabilizing selection in changing environments and the homogeneity cost. Evolution. 2005;59:1237–44.Mulder HA, Bijma P, Hill WG. Selection for uniformity in livestock by exploiting genetic heterogeneity of residual variance. Genet Sel Evol. 2008;40:37–59.Bodin L, Bolet G, Garcia M, Garreau H, Larzul C, David I. Robustesse et canalisation, vision de généticiens. INRA Prod Anim. 2010;23:11–22.García ML, Argente MJ, Muelas R, Birlanga V, Blasco A. Effect of divergent selection for residual variance of litter size on health status and welfare. In: Proceedings of the 10th World Rabbit Congress. Sharm El-Sheikh; 2012. p. 103–6.Argente MJ, García ML, Zbynovska K, Petruska P, Capcarova M, Blasco A. Effect of selection for residual variance of litter size on hematology parameters as immunology indicators in rabbits. In: Proceedings of the 10th World Congress on genetics applied to livestock production. Vancouver; 2014.García ML, Zbynovska K, Petruska P, Bovdisová I, Kalafová A, Capcarova M, et al. Effect of selection for residual variance of litter size on biochemical parameters in rabbits. In: Proceedings of the 67th annual meeting of the European Federation of Animal Science. Belfast; 2016.Broom DM. Welfare assessment and relevant ethical decisions: key concepts. Annu Rev Biomed Sci. 2008;20:79–90.SanCristobal-Gaudy M, Bodin L, Elsen JM, Chevalet C. Genetic components of litter size variability in sheep. Genet Sel Evol. 2001;33:249–71.Sorensen D, Waagepetersen R. Normal linear models with genetically structured residual variance heterogeneity: a case study. Genet Res. 2003;82:207–22.Mulder HA, Hill WG, Knol EF. Heritable environmental variance causes nonlinear relationships between traits: application to birth weight and stillbirth of pigs. Genetics. 2015;199:1255–69.Ros M, Sorensen D, Waagepetersen R, Dupont-Nivet M, San Cristobal M, Bonnet JC. Evidence for genetic control of adult weight plasticity in the snail Helix aspersa. Genetics. 2004;168:2089–97.Gutiérrez JP, Nieto B, Piqueras P, Ibáñez N, Salgado C. Genetic parameters for components analysis of litter size and litter weight traits at birth in mice. Genet Sel Evol. 2006;38:445–62.Ibáñez-Escriche N, Sorensen D, Waagepetersen R, Blasco A. Selection for environmental variation: a statistical analysis and power calculations to detect response. Genetics. 2008;180:2209–26.Wolc A, White IM, Avendano S, Hill WG. Genetic variability in residual variation of body weight and conformation scores in broiler chickens. Poult Sci. 2009;88:1156–61.Fina M, Ibáñez-Escriche N, Piedrafita J, Casellas J. Canalization analysis of birth weight in Bruna dels Pirineus beef cattle. J Anim Sci. 2013;91:3070–8.Mulder HA, Rönnegård L, Fikse WF, Veerkamp RF, Strandberg E. Estimation of genetic variance for macro- and micro-environmental sensitivity using double hierarchical generalized linear models. Genet Sel Evol. 2013;45:23.Janhunen M, Kause A, Vehviläinen H, Järvisalom O. Genetics of microenvironmental sensitivity of body weight in rainbow trout (Oncorhynchus mykiss) selected for improved growth. PLoS One. 2012;7:e38766.Sonesson AK, Ødegård J, Rönnegård L. Genetic heterogeneity of within-family variance of body weight in Atlantic salmon (Salmo salar). Genet Sel Evol. 2013;45:41.Garreau H, Bolet G, Larzul C, Robert-Granie C, Saleil G, SanCristobal M, et al. Results of four generations of a canalising selection for rabbit birth weight. Livest Sci. 2008;119:55–62.Pun A, Cervantes I, Nieto B, Salgado C, Pérez-Cabal MA, Ibáñez-Escriche N, et al. Genetic parameters for birth weight environmental variability in mice. J Anim Breed Genet. 2012;130:404–14.Hill WG, Mulder HA. Genetic analysis of environmental variation. Genet Res (Camb). 2010;92:381–95.Yang Y, Christensen OF, Sorensen D. Analysis of a genetically structured variance heterogeneity model using the Box–Cox transformation. Genet Res (Camb). 2011;93:33–46.Piles M, Garcia ML, Rafel O, Ramon J, Baselga M. Genetics of litter size in three maternal lines of rabbits: repeatability versus multiple-trait models. J Anim Sci. 2006;84:2309–15.Estany J, Baselga M, Blasco A, Camacho J. Mixed model methodology for the estimation of genetic response to selection in litter size of rabbits. Livest Prod Sci. 1989;21:67–75.Box GEP, Tiao GC. Bayesian inference in statistical analysis. New York: Wiley; 1973.Searle SR. Matrix algebra useful for statistics. Toronto: Wiley; 1982.Sorensen D, Gianola D. Likelihood, Bayesian and MCMC methods in quantitative genetics. New York: Springer; 2002.Geyer CM. Practical Markov chain Monte Carlo (with discussion). Stat Sci. 1992;7:467–511.Legarra A. TM threshold model. 2008. http://genoweb.toulouse.inra.fr/~alegarra/tm_folder/ . Accessed 02 May 2017.Blasco A. Bayesian data analysis for animal scientists. New York: Springer; 2017.Rönnegård L, Felleki M, Fikse F, Mulder HA, Strandberg E. Genetic heterogeneity of residual variance—estimation of variance components using double hierarchical generalized linear models. Genet Sel Evol. 2010;42:8.Felleki M, Lee D, Lee Y, Gilmour AR, Rönnegård L. Estimation of breeding values for mean and dispersion, their variance and correlation using double hierarchical generalized linear models. Genet Res (Camb). 2012;94:307–17.Thompson R. Estimation of realized heritability in a selected population using mixed model methods. Genet Sel Evol. 1986;18:475–84.Sorensen DA, Johansson K. Estimation of direct and correlated responses to selection using univariate animal models. J Anim Sci. 1992;70:2038–44.Popper K. The logic of scientific discovery. London: Hutchinson & Co; 1959.Falconer DS, MacKay TFC. An introduction to quantitative genetics. 4th ed. Harlow: Longman Group Ltd; 1996.Formoso-Rafferty N, Cervantes I, Ibáñez-Escriche N, Gutiérrez JP. Correlated genetic trends for production and welfare traits in a mouse population divergently selected for birth weight environmental variability. Animal. 2016;10:1770–7.Ibáñez-Escriche N, Moreno A, Nieto B, Piqueras P, Salgado C, Gutiérrez JP. Genetic parameters related to environmental variability of weight traits in a selection experiment for weight gain in mice; signs of correlated canalised response. Genet Sel Evol. 2008;40:279–93.Mulder HA, Hill WG, Vereijken A, Veerkamp RF. Estimation of genetic variation in residual variance in female and male broiler chickens. Animal. 2009;3:1673–80.Ibáñez-Escriche N, Varona L, Sorensen D, Noguera JL. A study of heterogeneity of environmental variance for slaughter weight in pigs. Animal. 2008;2:19–26.Bolet G, Garreau H, Hurtaud J, Saleil G, Esparbié J, Falieres J. Canalising selection on within litter variability of birth weight in rabbits: responses to selection and characteristics of the uterus of the does. In: Proceedings of the 9th World Rabbit Congress. Verona; 2008. p. 51–6.San Cristobal-Gaudy M, Elsen JM, Bodin L, Chevalet C. Prediction of the response to a selection for canalisation of a continuous trait in animal breeding. Genet Sel Evol. 1998;30:423–51.Argente MJ, Santacreu MA, Climent A, Blasco A. Genetic correlations between litter size and uterine capacity. In: Proceeding of the 8th World Rabbit Congress. Valencia; 2000. p. 333–38.Rauw WM. Immune response from a resource allocation perspective. Front Genet. 2012;3:267

Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience

Convection-enhanced delivery (CED) of highly stable PEGylated liposomes encapsulating chemotherapeutic drugs has previously been effective against malignant glioma xenografts. We have developed a novel, convectable non-PEGylated liposomal formulation that can be used to encapsulate both the topoisomerase I inhibitor topotecan (topoCED™) and paramagnetic gadodiamide (gadoCED™), providing an ideal basis for real-time monitoring of drug distribution. Tissue retention of topoCED following single CED administration was significantly improved relative to free topotecan. At a dose of 10 μg (0.5 mg/ml), topoCED had a half-life in brain of approximately 1 day and increased the area under the concentration–time curve (AUC) by 28-fold over free topotecan (153.8 vs. 5.5 μg day/g). The combination of topoCED and gadoCED was found to co-convect well in both naïve rat brain and malignant glioma xenografts (correlation coefficients 0.97–0.99). In a U87MG cell assay, the 50% inhibitory concentration (IC50) of topoCED was approximately 0.8 μM at 48 and 72 h; its concentration–time curves were similar to free topotecan and unaffected by gadoCED. In a U87MG intracranial rat xenograft model, a two-dose CED regimen of topoCED co-infused with gadoCED greatly increased median overall survival at dose levels of 0.5 mg/ml (29.5 days) and 1.0 mg/ml (33.0 days) vs. control (20.0 days; P < 0.0001 for both comparisons). TopoCED at higher concentrations (1.6 mg/ml) co-infused with gadoCED showed no evidence of histopathological changes attributable to either agent. The positive results of tissue pharmacokinetics, co-convection, cytotoxicity, efficacy, and lack of toxicity of topoCED in a clinically meaningful dose range, combined with an ideal matched-liposome paramagnetic agent, gadoCED, implicates further clinical applications of this therapy in the treatment of malignant glioma